Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BIA Separations Appoints New CSO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

BIA Separations Appoints New CSO

Gagnon comes with more than three decades of experience in the biotech industry

By: Betsy Louda

, Contract Pharma

BIA Separations, a biochromatography development and manufacturing company, has appointed Pete Gagnon as chief scientific officer. In his new role, he will drive the company’s new product and applications development, with a focus on the purification and increased safety of products for gene therapy, oncolytic vaccines, exosomes, and more.

 

Gagnon brings over 30 years of experience in the biotech industry, where the majority of his experience was in the development of commercial purification procedures for recombinant human therapeutics. He was most recently president and chief scientific officer of Validated Biosystems.

 

Aleš Štrancar, chief executive officer of BIA Separations, said, “Pete’s scientific interests and experience are a perfect fit with our future development strategy and the stringent requirements associated with these classes of products. He has been an influential researcher and a user of BIA’s proprietary CIM monolith technology for more than a decade, and his enthusiasm, practical skills and insights will make him an invaluable resource for our customers and partners, especially in the fast-developing and challenging fields of virus and exosome purification.”

 

Gagnon is also the inventor of 20 granted patent families with 20 more pending, and has published more than 80 articles. He is cited in more than 700 scientific publications, and has authored a book titled ‘Purification Tools for Monoclonal Antibodies’.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics